Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02199587
What this trial is testing

The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test

Who this might be right for
Precocious PubertyGrowth Hormone Tests
Meir Medical Center 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05607004
What this trial is testing

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Who this might be right for
Breast NeoplasmsInvasive Breast CancerEstrogen-receptor-positive Breast Cancer+1 more
Atossa Therapeutics, Inc. 87
Not applicableStudy completedNCT04671615
What this trial is testing

Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Who this might be right for
Metastatic Breast Cancer
Pfizer 559
Post-approval studies (Phase 4)Study completedNCT01897324
What this trial is testing

IVF/ICSI Protocols in Poor Responders With Growth Hormone

Who this might be right for
Female Infertility Due to Diminished Ovarian Reserve
Woman's Health University Hospital, Egypt 287
Not applicableEnded earlyNCT02018172
What this trial is testing

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

Who this might be right for
Growth Hormone DeficiencyTurner's Syndrome
Ferring Pharmaceuticals 3
Large-scale testing (Phase 3)Ended earlyNCT00174291
What this trial is testing

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Who this might be right for
Endocrine System Diseases
Pfizer 21
Very early researchUnknownNCT05660356
What this trial is testing

Growth Hormone Deficiency in Mild Traumatic Brain Injury

Who this might be right for
Growth Hormone TreatmentGrowth Hormone DeficiencyConcussion, Mild+1 more
University of Calgary 20
Large-scale testing (Phase 3)Study completedNCT00781547
What this trial is testing

Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

Who this might be right for
Abdominal ObesityMetabolic SyndromeObesity
Göteborg University 40
Not applicableStudy completedNCT01616095
What this trial is testing

Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

Who this might be right for
Growth Hormone Deficiency
Slovak Academy of Sciences 44
Large-scale testing (Phase 3)Study completedNCT03033121
What this trial is testing

Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

Who this might be right for
Growth Hormone Treatment
University of Palermo 32
Large-scale testing (Phase 3)WithdrawnNCT00256555
What this trial is testing

Growth Hormone Treatment Study in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00294918
What this trial is testing

An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 142
Large-scale testing (Phase 3)UnknownNCT06007417
What this trial is testing

Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Who this might be right for
GHD
Changchun GeneScience Pharmaceutical Co., Ltd. 162
Testing effectiveness (Phase 2)Looking for participantsNCT07498478
What this trial is testing

Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment

Who this might be right for
Breast Cancer
TransThera Sciences (Nanjing), Inc. 94
Not applicableStudy completedNCT01363674
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 180
Not applicableUnknownNCT02801565
What this trial is testing

Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

Who this might be right for
Polycystic Ovary Syndrome
Changchun GeneScience Pharmaceutical Co., Ltd. 208
Not applicableStudy completedNCT01438528
What this trial is testing

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04806854
What this trial is testing

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

Who this might be right for
Growth Hormone Deficiency
Lumos Pharma 24
Large-scale testing (Phase 3)Study completedNCT00184691
What this trial is testing

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 78
Not applicableStudy completedNCT07498413
What this trial is testing

Epidemiology and Treatment of HR+/HER2- Breast Cancer in England

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 218,677
Next Page